Radiation-induced mitotic delay of exponentially growing populations (immediate decline of mitotic index followed by recovery of mitotic index) was studied in cultured mouse leukemic (L5178Y) cells by using five different methods of localizing the site of the radiation-induced block of cell progress in their life cycle. This was compared with the site of the blocks caused by actinomycin D and puromycin and with the time of switching-off of RNA synthesis. It was found that the x-ray block induced by 200 rads occurred in the middle of the G2 stage; the puromycin-induced block (10 μg/ml) also occurred in the middle of the G2 stage; however, the actinomycin D-induced block (0.5 μg/ml) was localized somewhere at the late S or in the early G2 stage. The switching-off time of RNA synthesis was about 10 minutes before the end of the G2 stage. In the recovery phase of mitotic delay, actinomycin D (0.5 μg/ml), ouabain (10-4 M), and dinitrophenol (10-4 M) failed to interfere with the reappearance of mitotic cells, but puromycin (10μg/ml) significantly interfered with recovery from the mitotic block. From these results, it is concluded that radiation-induced mitotic delay is caused by a complete but transient blockage of cell progress in the middle of the G2 stage, and it is speculated that radiation-induced mitotic delay involves inhibition of protein synthesis.
Skip Nav Destination
Close
Article navigation
1 June 1969
Research Article|
June 01 1969
Radiation-Induced Mitotic Delay in Cultured Mammalian Cells (L5178Y)
Radiat Res (1969) 38 (3): 513–529.
Citation
Y. Doida, S. Okada; Radiation-Induced Mitotic Delay in Cultured Mammalian Cells (L5178Y). Radiat Res 1 June 1969; 38 (3): 513–529. doi: https://doi.org/10.2307/3572611
Download citation file:
Close
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your InstitutionCiting articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner
Photon GRID Radiation Therapy: A Physics and Dosimetry White Paper from the Radiosurgery Society (RSS) GRID/LATTICE, Microbeam and FLASH Radiotherapy Working Group
Hualin Zhang, Xiaodong Wu, Xin Zhang, Sha X. Chang, Ali Megooni, Eric D. Donnelly, Mansoor M. Ahmed, Robert J. Griffin, James S. Welsh, Charles B. Simone, II, Nina A. Mayr